首页 > 最新文献

Clinical Orthopaedics and Related Research®最新文献

英文 中文
CORR® Curriculum-Orthopaedic Education: Artificial Intelligence and Surgical Assessment. CORR® 课程-骨科教育:人工智能与手术评估。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-09-03 DOI: 10.1097/CORR.0000000000003235
Paul J Dougherty, Pamela Andreatta
{"title":"CORR® Curriculum-Orthopaedic Education: Artificial Intelligence and Surgical Assessment.","authors":"Paul J Dougherty, Pamela Andreatta","doi":"10.1097/CORR.0000000000003235","DOIUrl":"https://doi.org/10.1097/CORR.0000000000003235","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CORR Insights®: Taper Junction Subsidence Occurs in Modular Tumor Endoprostheses: How Concerned Should We Be? CORR Insights®:模块化肿瘤内固定器出现锥形接合处下沉:我们应该如何关注?
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-09-03 DOI: 10.1097/CORR.0000000000003246
Magdalena Maria Gilg
{"title":"CORR Insights®: Taper Junction Subsidence Occurs in Modular Tumor Endoprostheses: How Concerned Should We Be?","authors":"Magdalena Maria Gilg","doi":"10.1097/CORR.0000000000003246","DOIUrl":"https://doi.org/10.1097/CORR.0000000000003246","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: How to Make the Most of Open Notes. 社论:如何充分利用开放式笔记。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-09-03 DOI: 10.1097/CORR.0000000000003197
Seth S Leopold, Clare M Rimnac, David Ring
{"title":"Editorial: How to Make the Most of Open Notes.","authors":"Seth S Leopold, Clare M Rimnac, David Ring","doi":"10.1097/CORR.0000000000003197","DOIUrl":"https://doi.org/10.1097/CORR.0000000000003197","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Total Shoulder Arthroplasty in Patients With Hemophilia A: Greater Odds of Postoperative Bleeding and Thromboembolic Events but No Difference in 5-year Implant Survival. 血友病 A 患者的全肩关节置换术:术后出血和血栓栓塞事件的几率更大,但 5 年植入存活率无差异。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-09-03 DOI: 10.1097/CORR.0000000000003209
Stephen M Gillinov, Maxwell Modrak, Nancy Park, Peter F Monahan, Christopher V Wilhelm, Michael S Lee, Ronak J Mahatme, Scott Fong, Jay Moran, Jonathan N Grauer, Andrew E Jimenez

Background: Patients with hemophilia A can develop joint hemarthroses, degenerative changes, and eventually undergo total shoulder arthroplasty (TSA). Few data exist concerning complications and prosthesis survival after TSA in this population.

Questions/purposes: (1) Is hemophilia A associated with more bleeding and thromboembolic adverse events after TSA relative to matched controls? (2) Is 5-year TSA prosthesis survival reduced in patients with hemophilia A compared with matched controls?

Methods: The 2010 to 2022 PearlDiver M161 database was used to identify patients who underwent primary anatomic or reverse TSA. Given that the X-linked recessive condition hemophilia A presents nearly exclusively in males, male patients with hemophilia A who underwent TSA were matched 1:10 with male patients without hemophilia who underwent TSA based on age and Elixhauser comorbidity index (ECI). This yielded 73 patients with hemophilia A who underwent TSA who were matched 1:10 with 729 patients without hemophilia. Ninety-day adverse events were compared with multivariable analysis. Revision within 5 years was assessed using Kaplan-Meier analysis.

Results: Compared with the control cohort, patients with hemophilia had greater odds of bleeding issues (hematoma, OR 6.8 [95% CI 3.0 to 15.3]; p < 0.001; anemia, OR 2.5 [95% CI 1.5 to 4.2]; p < 0.001, transfusion, OR 5.0 [95% CI 2.4 to 10.3]; p < 0.001), venous thromboembolic events (VTE) (OR 1.9 [95% CI 1.1 to 3.1]; p = 0.01), and prosthetic loosening (OR 3.5 [95% CI 1.4 to 8.0]; p = 0.004). Based on available data, 5-year implant survival was not different in patients with hemophilia (97.3% [95% CI 93.6% to 100.0%]) relative to matched controls (95.2% [95% CI 93.4% to 97.2%]; p = 0.60).

Conclusion: The elevated risks of both 90-day bleeding complications (hematoma, anemia, and transfusion) and VTE (DVT and PE) in patients with hemophilia emphasize the special challenges of carefully balancing factor replacement and VTE prophylaxis pre-, intra-, and postoperatively on an individual patient basis with careful hematologist coordination. Further study on Factor VIII levels and targets as well as tranexamic acid and VTE prophylaxis in this population is necessary to provide further guidance. Furthermore, 5-year implant survival was not different between patients with hemophilia and matched controls (patients without hemophilia) based on available data, suggesting that TSA survivorship remains durable and may be offered to patients in this population as indicated.

Level of evidence: Level III, therapeutic study.

背景:A 型血友病患者会出现关节肉芽肿、退行性病变,并最终接受全肩关节置换术(TSA)。问题/目的:(1)与匹配的对照组相比,血友病 A 患者在接受全肩关节置换术(TSA)后是否会发生更多出血和血栓栓塞不良事件?(2) 与匹配对照组相比,血友病 A 患者的 5 年 TSA 假体存活率是否降低?利用 2010 年至 2022 年的 PearlDiver M161 数据库确定接受原发性解剖或反向 TSA 的患者。鉴于X连锁隐性血友病A几乎只发生在男性身上,因此根据年龄和Elixhauser合并症指数(ECI),将接受TSA的男性血友病A患者与接受TSA的男性非血友病患者进行1:10配对。这样,73 名接受 TSA 的 A 型血友病患者与 729 名无血友病的患者进行了 1:10 匹配。通过多变量分析比较了九十天内的不良事件。采用卡普兰-梅耶尔分析法评估了5年内的翻修情况:与对照组相比,血友病患者出现出血问题的几率更大(血肿,OR 6.8 [95% CI 3.0 至 15.3];p < 0.001;贫血,OR 2.5 [95% CI 1.5 至 4.2];p < 0.001,输血,OR 5.0 [95% CI 2.4 to 10.3];p < 0.001)、静脉血栓栓塞事件(VTE)(OR 1.9 [95% CI 1.1 to 3.1];p = 0.01)和假体松动(OR 3.5 [95% CI 1.4 to 8.0];p = 0.004)。根据现有数据,血友病患者的 5 年植入存活率(97.3% [95% CI 93.6% 到 100.0%])与匹配对照组(95.2% [95% CI 93.4% 到 97.2%];P = 0.60)相比没有差异:血友病患者 90 天出血并发症(血肿、贫血和输血)和 VTE(深静脉血栓和 PE)的风险都很高,这凸显了在血液科医生的精心协调下,根据患者个体情况谨慎平衡因子替代和术前、术中和术后 VTE 预防的特殊挑战。有必要对这一人群的因子 VIII 水平和目标以及氨甲环酸和 VTE 预防进行进一步研究,以提供更多指导。此外,根据现有数据,血友病患者与匹配对照组(无血友病患者)的 5 年植入存活率并无差异,这表明 TSA 的存活率仍然持久,可根据需要提供给这一人群中的患者:证据等级:三级,治疗研究。
{"title":"Total Shoulder Arthroplasty in Patients With Hemophilia A: Greater Odds of Postoperative Bleeding and Thromboembolic Events but No Difference in 5-year Implant Survival.","authors":"Stephen M Gillinov, Maxwell Modrak, Nancy Park, Peter F Monahan, Christopher V Wilhelm, Michael S Lee, Ronak J Mahatme, Scott Fong, Jay Moran, Jonathan N Grauer, Andrew E Jimenez","doi":"10.1097/CORR.0000000000003209","DOIUrl":"https://doi.org/10.1097/CORR.0000000000003209","url":null,"abstract":"<p><strong>Background: </strong>Patients with hemophilia A can develop joint hemarthroses, degenerative changes, and eventually undergo total shoulder arthroplasty (TSA). Few data exist concerning complications and prosthesis survival after TSA in this population.</p><p><strong>Questions/purposes: </strong>(1) Is hemophilia A associated with more bleeding and thromboembolic adverse events after TSA relative to matched controls? (2) Is 5-year TSA prosthesis survival reduced in patients with hemophilia A compared with matched controls?</p><p><strong>Methods: </strong>The 2010 to 2022 PearlDiver M161 database was used to identify patients who underwent primary anatomic or reverse TSA. Given that the X-linked recessive condition hemophilia A presents nearly exclusively in males, male patients with hemophilia A who underwent TSA were matched 1:10 with male patients without hemophilia who underwent TSA based on age and Elixhauser comorbidity index (ECI). This yielded 73 patients with hemophilia A who underwent TSA who were matched 1:10 with 729 patients without hemophilia. Ninety-day adverse events were compared with multivariable analysis. Revision within 5 years was assessed using Kaplan-Meier analysis.</p><p><strong>Results: </strong>Compared with the control cohort, patients with hemophilia had greater odds of bleeding issues (hematoma, OR 6.8 [95% CI 3.0 to 15.3]; p < 0.001; anemia, OR 2.5 [95% CI 1.5 to 4.2]; p < 0.001, transfusion, OR 5.0 [95% CI 2.4 to 10.3]; p < 0.001), venous thromboembolic events (VTE) (OR 1.9 [95% CI 1.1 to 3.1]; p = 0.01), and prosthetic loosening (OR 3.5 [95% CI 1.4 to 8.0]; p = 0.004). Based on available data, 5-year implant survival was not different in patients with hemophilia (97.3% [95% CI 93.6% to 100.0%]) relative to matched controls (95.2% [95% CI 93.4% to 97.2%]; p = 0.60).</p><p><strong>Conclusion: </strong>The elevated risks of both 90-day bleeding complications (hematoma, anemia, and transfusion) and VTE (DVT and PE) in patients with hemophilia emphasize the special challenges of carefully balancing factor replacement and VTE prophylaxis pre-, intra-, and postoperatively on an individual patient basis with careful hematologist coordination. Further study on Factor VIII levels and targets as well as tranexamic acid and VTE prophylaxis in this population is necessary to provide further guidance. Furthermore, 5-year implant survival was not different between patients with hemophilia and matched controls (patients without hemophilia) based on available data, suggesting that TSA survivorship remains durable and may be offered to patients in this population as indicated.</p><p><strong>Level of evidence: </strong>Level III, therapeutic study.</p>","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CORR Insights®: Mini-open Femoroacetabular Osteoplasty in Patients With Tönnis Grade 2 or Higher Osteoarthritis is Associated With a Higher Risk of Subsequent Conversion to THA. CORR Insights®:Tönnis 2 级或更高骨关节炎患者进行微开腹股骨髋臼骨成形术后转为 THA 的风险更高。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-09-01 Epub Date: 2024-01-25 DOI: 10.1097/CORR.0000000000002979
Melissa Allen
{"title":"CORR Insights®: Mini-open Femoroacetabular Osteoplasty in Patients With Tönnis Grade 2 or Higher Osteoarthritis is Associated With a Higher Risk of Subsequent Conversion to THA.","authors":"Melissa Allen","doi":"10.1097/CORR.0000000000002979","DOIUrl":"10.1097/CORR.0000000000002979","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343516/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139546082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editor's Spotlight/Take 5: Arthroscopic Partial Meniscectomy for a Degenerative Meniscus Tear Is Not Cost Effective Compared With Placebo Surgery: An Economic Evaluation Based on the FIDELITY Trial Data. 编辑聚焦/第 5 期:关节镜下半月板部分切除术治疗退行性半月板撕裂与安慰剂手术相比不具成本效益:基于 FIDELITY 试验数据的经济评估。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-09-01 Epub Date: 2024-08-16 DOI: 10.1097/CORR.0000000000003214
Seth S Leopold
{"title":"Editor's Spotlight/Take 5: Arthroscopic Partial Meniscectomy for a Degenerative Meniscus Tear Is Not Cost Effective Compared With Placebo Surgery: An Economic Evaluation Based on the FIDELITY Trial Data.","authors":"Seth S Leopold","doi":"10.1097/CORR.0000000000003214","DOIUrl":"10.1097/CORR.0000000000003214","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343517/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141999511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CORR Insights®: Does Periacetabular Osteotomy Change Sagittal Spinopelvic Alignment? CORR Insights®:髋臼周围截骨术是否会改变矢状脊柱对齐?
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-09-01 Epub Date: 2024-04-25 DOI: 10.1097/CORR.0000000000003095
Benjamin F Ricciardi
{"title":"CORR Insights®: Does Periacetabular Osteotomy Change Sagittal Spinopelvic Alignment?","authors":"Benjamin F Ricciardi","doi":"10.1097/CORR.0000000000003095","DOIUrl":"10.1097/CORR.0000000000003095","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140847501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Hip Dislocation in the Era of Hip Arthroscopy Demonstrates High Survivorship and Improvements in Patient-reported Outcomes for Complex Femoroacetabular Impingement. 髋关节镜时代的髋关节脱位手术显示了复杂股骨髋臼撞击症的高存活率和患者报告结果的改善。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-09-01 Epub Date: 2024-03-21 DOI: 10.1097/CORR.0000000000003032
Zachary Trotzky, Brian Muffly, Nora Cao, Ernest Sink
<p><strong>Background: </strong>Over the past decade, hip arthroscopy has become more commonly used in the treatment of patients with femoroacetabular impingement (FAI) as well as those with many other intra-articular hip pathologies. As such, the indications for open surgical hip dislocation have narrowed to include complex intra-articular and extra-articular bony morphologies and revision hip preservation. Although surgical hip dislocation has been established as an effective approach, previous research using contemporary indications has been limited primarily to smaller cohorts with short-term follow-up. Furthermore, factors associated with reoperation, conversion arthroplasty, and not achieving clinical improvement remain ambiguous.</p><p><strong>Questions/purposes: </strong>At a minimum of 2 years of follow-up in patients treated for FAI with surgical hip dislocation, (1) how much did patient-reported outcome measures (PROMs) improve, and what percentage of patients achieved the minimum clinically important difference (MCID) and patient-acceptable symptom state (PASS)? (2) What was the survivorship free from reoperation of the hip for any reason? (3) What was the survivorship free from conversion to arthroplasty (THA or hip resurfacing)?</p><p><strong>Methods: </strong>Between February 2011 and April 2021, 211 patients were treated at one academic institution with surgical dislocation and osteoplasty of the femoral head-neck junction or greater trochanter for FAI. Of these, patients with concomitant diagnoses including Legg-Calvé-Perthes disease, slipped capital femoral epiphysis, osteochondritis dissecans, a benign tumor, or another neurologic or metabolic disorder were excluded. This yielded 74% (156 of 211) of patients as potentially eligible. A further 12% (18 of 156) of patients without postoperative PROMs were excluded, and another 13% (21 of 156) were lost before the minimum study follow-up of 2 years, leaving 75% (117) for analysis at a median of 4.9 years (range 2 to 12 years) in this retrospective study. A total of 88% of the patients were women (103 of 117), and 40% (47 patients) underwent the procedure as a revision. All patients underwent surgical hip dislocation. Intraoperatively, 66% (77 of 117) of patients demonstrated cam impingement, and the remainder had either pincer impingement or combined cam and pincer; 82% (96 of 117) had some component of extra-articular impingement. To answer our first research question, we obtained PROM scores for the modified Harris hip score (mHHS) and international hip outcome tool 12 (iHOT-12) before surgery and at the most-recent follow-up from our longitudinally maintained institutional database, and we determined the percentage of patients who achieved the MCID or PASS. To answer our second research question, we calculated Kaplan-Meier survivorship free from any reoperation on the hip at 5.8 years (mean follow-up) after the index procedure. To answer our third research question, we calculate
手术髋关节脱位8年后的复发率为75%(95% CI为60%至95%)。手术髋关节脱位为主要髋关节手术的患者中没有人转为接受关节成形术。在翻修患者队列中,手术髋关节脱位后5.8年未转为关节成形术的存活率为97%(95% CI 91%至100%):手术髋关节脱位可有效改善髋关节疼痛和功能,对不太适合关节镜治疗的复杂关节内和关节外FAI患者具有较高的存活率(无再次手术或转为关节成形术),但当该手术用于既往接受过髋关节手术的患者时,应告知他们翻修手术是现实存在的可能性。如果预计髋臼覆盖不足,应考虑进行髋臼重新定位截骨术。未来的研究应在更大的患者群体中评估长期存活率和PROMs,并确定与再次手术和转为关节成形术相关的其他因素:证据等级:III级,治疗性研究。
{"title":"Surgical Hip Dislocation in the Era of Hip Arthroscopy Demonstrates High Survivorship and Improvements in Patient-reported Outcomes for Complex Femoroacetabular Impingement.","authors":"Zachary Trotzky, Brian Muffly, Nora Cao, Ernest Sink","doi":"10.1097/CORR.0000000000003032","DOIUrl":"10.1097/CORR.0000000000003032","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Over the past decade, hip arthroscopy has become more commonly used in the treatment of patients with femoroacetabular impingement (FAI) as well as those with many other intra-articular hip pathologies. As such, the indications for open surgical hip dislocation have narrowed to include complex intra-articular and extra-articular bony morphologies and revision hip preservation. Although surgical hip dislocation has been established as an effective approach, previous research using contemporary indications has been limited primarily to smaller cohorts with short-term follow-up. Furthermore, factors associated with reoperation, conversion arthroplasty, and not achieving clinical improvement remain ambiguous.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Questions/purposes: &lt;/strong&gt;At a minimum of 2 years of follow-up in patients treated for FAI with surgical hip dislocation, (1) how much did patient-reported outcome measures (PROMs) improve, and what percentage of patients achieved the minimum clinically important difference (MCID) and patient-acceptable symptom state (PASS)? (2) What was the survivorship free from reoperation of the hip for any reason? (3) What was the survivorship free from conversion to arthroplasty (THA or hip resurfacing)?&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Between February 2011 and April 2021, 211 patients were treated at one academic institution with surgical dislocation and osteoplasty of the femoral head-neck junction or greater trochanter for FAI. Of these, patients with concomitant diagnoses including Legg-Calvé-Perthes disease, slipped capital femoral epiphysis, osteochondritis dissecans, a benign tumor, or another neurologic or metabolic disorder were excluded. This yielded 74% (156 of 211) of patients as potentially eligible. A further 12% (18 of 156) of patients without postoperative PROMs were excluded, and another 13% (21 of 156) were lost before the minimum study follow-up of 2 years, leaving 75% (117) for analysis at a median of 4.9 years (range 2 to 12 years) in this retrospective study. A total of 88% of the patients were women (103 of 117), and 40% (47 patients) underwent the procedure as a revision. All patients underwent surgical hip dislocation. Intraoperatively, 66% (77 of 117) of patients demonstrated cam impingement, and the remainder had either pincer impingement or combined cam and pincer; 82% (96 of 117) had some component of extra-articular impingement. To answer our first research question, we obtained PROM scores for the modified Harris hip score (mHHS) and international hip outcome tool 12 (iHOT-12) before surgery and at the most-recent follow-up from our longitudinally maintained institutional database, and we determined the percentage of patients who achieved the MCID or PASS. To answer our second research question, we calculated Kaplan-Meier survivorship free from any reoperation on the hip at 5.8 years (mean follow-up) after the index procedure. To answer our third research question, we calculate","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343553/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140183930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CORR Insights®: Low Rate of AVN and Complications in Unstable SCFE With Epiphyseal-metaphyseal Discontinuity After Treatment With a Modified Dunn Procedure. CORR Insights®:采用改良邓恩手术治疗不稳定的 SCFE 伴有骺端-金属骺端不连续的患者,其 AVN 和并发症发生率较低。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-09-01 Epub Date: 2024-07-16 DOI: 10.1097/CORR.0000000000003149
Rachel M Thompson
{"title":"CORR Insights®: Low Rate of AVN and Complications in Unstable SCFE With Epiphyseal-metaphyseal Discontinuity After Treatment With a Modified Dunn Procedure.","authors":"Rachel M Thompson","doi":"10.1097/CORR.0000000000003149","DOIUrl":"10.1097/CORR.0000000000003149","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to the Letter to the Editor: Variations in 1-year Trajectories of Levels of Pain and Capability After Shoulder Arthroplasty Are Associated With Baseline Mental Health. 回复致编辑的信:肩关节置换术后1年疼痛和能力水平的变化轨迹与基线心理健康有关。
IF 4.2 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-09-01 Epub Date: 2024-06-19 DOI: 10.1097/CORR.0000000000003165
Niels Brinkman, David Ring, Michel van den Bekerom
{"title":"Reply to the Letter to the Editor: Variations in 1-year Trajectories of Levels of Pain and Capability After Shoulder Arthroplasty Are Associated With Baseline Mental Health.","authors":"Niels Brinkman, David Ring, Michel van den Bekerom","doi":"10.1097/CORR.0000000000003165","DOIUrl":"10.1097/CORR.0000000000003165","url":null,"abstract":"","PeriodicalId":10404,"journal":{"name":"Clinical Orthopaedics and Related Research®","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141436343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Orthopaedics and Related Research®
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1